| Deler fremragende | 15,615,786 shares |
| Insideraktier | 9.414.022 shares |
| Insider ejerskab | 60,29 % |
| Total Insiders | 44 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Neurogene Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Kamran Alam CFO, Vice President Finance - [O] | 0 | 0 | |
|
Baker Bros. Advisors Lp
Director, 10% Owner -
[D]
|
1.658.190 | 1.658.190 | |
|
Julian Baker
10% Owner -
|
3.501.691 | 1.658.190 | |
| Martin Babler | 25.000 | ||
|
Baker Bros. Advisors (GP) LLC
10% Owner -
|
25.000 | 1.658.190 | |
| Meta Cantey Boyd | 0 | ||
| Gary Bridger Director - [D] | 0 | 0 | |
| Stuart Cobb Chief Scientific Officer - [O] | 30.497 | 30.497 | |
| Donna Cochener | 400.000 | ||
| Christine Mikail Cvijic President and CFO - [O] | 103.240 | 103.240 | |
| Jonathan G Drachman President and CEO, Director - [D] [O] | 100.000 | 20.000 | |
|
Jeremy Green
10% Owner -
|
4.041.211 | 1.546.632 | |
| Robert Ho Chief Financial Officer - [O] | 21.503 | 4.301 | |
|
& Johnson Johnson
10% Owner -
|
100.000 | 100.000 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Abigail Jenkins Chief Commercial Officer - [O] | 0 | 0 | |
|
Johnson & Johnson Innovation - JJDC, Inc.
10% Owner -
|
100.000 | 100.000 | |
| Elaine V Jones Director - [D] | 0 | 0 | |
| Julie Jordan Chief Medical Officer - [O] | 12.472 | 12.472 | |
| Daniel J Levitt Director - [D] | 0 | 0 | |
| Erin Lavelle | 25.000 | ||
| Lavelle Erin M. | 0 | ||
| Richard S Levy | 0 | ||
| Lloyd MacKenzie Chief Operating Officer - [O] | 0 | 0 | |
| David Main President and CEO, Director - [D] [O] | 71.530 | 71.530 | |
| Shelley McCloskey VP, HR and Administration - [O] | 0 | 0 | |
| Rachel McMinn Chief Executive Officer, Director - [D] [O] | 1.344.307 | 1.344.307 | |
| David Chilton Mitchell VP Global Regulatory & Quality - [O] | 3.575 | 3.575 | |
| Kelvin Neu Director - [D] | 72 | 72 | |
| Nolan Sean P. | 25.000 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Noonberg Sarah B. | 25.000 | ||
| Rohan Palekar | 25.000 | ||
|
Pfizer Inc
10% Owner -
|
975.403 | 975.403 | |
| Priti Patel - | 37.313 | 7.463 | |
| Robert Pelzer | 15.000 | ||
|
Redmile Group, LLC
10% Owner -
|
7.733.158 | 1.546.632 | |
| Stephen B Shrewsbury CMO; Senior VP Clinical Dev. - [O] | 400 | 400 | |
| Todd E Simpson Director - [D] | 0 | 0 | |
|
Samsara BioCapital GP, LLC
10% Owner -
|
1.717.127 | 1.717.127 | |
| Sean Michael Smith Interim CFO, Prin Acct Off - [O] | 21.637 | 4.327 | |
| Barbara Troupin Chief Medical Officer - [O] | 0 | 0 | |
| Holly Vance | 100.000 | ||
|
Ventures West 8 Limited Partnership
10% Owner -
|
1.543.989 | 1.543.989 | |
| Carl Walkey Senior Vice President - [O] | 1.352.489 | 270.498 | |
| Lewis T Williams | 25.000 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i NGNE / Neurogene Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i NGNE / Neurogene Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-30 | 2026-03-26 | 4 | Cvijic Christine Mikail | NGNE | Common Stock | D | 21,6247 | -2.558 | -55 | 103.240 | ||||
| 2026-03-30 | 2026-03-26 | 4 | Jordan Julie | NGNE | Common Stock | D | 21,8932 | -828 | -18 | 12.472 | ||||
| 2026-03-30 | 2026-03-26 | 4 | McMinn Rachel | NGNE | Common Stock | D | 22,0749 | -3.352 | -74 | 1.344.307 | ||||
| 2026-03-17 | 2026-03-13 | 4 | Cvijic Christine Mikail | NGNE | Common Stock | D | 22,0195 | -263 | -6 | 105.798 | ||||
| 2026-03-17 | 2026-03-13 | 4 | Cvijic Christine Mikail | NGNE | Common Stock | D | 21,2451 | -1.395 | -30 | 106.061 | ||||
| 2026-03-17 | 2026-03-13 | 4 | Cvijic Christine Mikail | NGNE | Common Stock | D | 20,4224 | -2.387 | -49 | 107.456 | ||||
| 2026-03-17 | 2026-03-13 | 4 | Cobb Stuart | NGNE | Common Stock | D | 22,0800 | -148 | -3 | 30.497 | ||||
| 2026-03-17 | 2026-03-13 | 4 | Cobb Stuart | NGNE | Common Stock | D | 21,3400 | -2.658 | -57 | 30.645 | ||||
| 2026-03-17 | 2026-03-13 | 4 | Cobb Stuart | NGNE | Common Stock | D | 20,4100 | -3.991 | -81 | 33.303 | ||||
| 2026-03-03 | 2026-02-27 | 4 | Cvijic Christine Mikail | NGNE | Common Stock | D | 25,1096 | -4.800 | -121 | 109.843 | ||||
| 2026-02-24 | 2026-02-20 | 4 | Cobb Stuart | NGNE | Common Stock | D | 16.500 | 37.294 | ||||||
| 2026-02-24 | 2026-02-20 | 4 | Cvijic Christine Mikail | NGNE | Common Stock | D | 22.000 | 114.643 | ||||||
| 2026-02-24 | 2026-02-20 | 4 | Jordan Julie | NGNE | Common Stock | D | 4.900 | 13.300 | ||||||
| 2026-02-24 | 2026-02-20 | 4 | McMinn Rachel | NGNE | Common Stock | D | 25.900 | 1.347.659 | ||||||
| 2025-05-15 | 2025-05-14 | 4 | Cobb Stuart | NGNE | Common Stock | D | 15,1542 | -6.797 | -103 | 20.794 | ||||
| 2025-03-28 | 2025-03-26 | 4 | Cobb Stuart | NGNE | Common Stock | D | 7.200 | 27.591 | ||||||
| 2025-03-28 | 2025-03-26 | 4 | Cvijic Christine Mikail | NGNE | Common Stock | D | 20.300 | 92.643 | ||||||
| 2025-03-28 | 2025-03-26 | 4 | Jordan Julie | NGNE | Common Stock | D | 8.400 | 8.400 | ||||||
| 2025-03-28 | 2025-03-26 | 4 | McMinn Rachel | NGNE | Common Stock | D | 23.900 | 1.274.259 | ||||||
| 2025-03-17 | 2025-03-13 | 4 | Cvijic Christine Mikail | NGNE | Common Stock | D | 16,9400 | -4.501 | -76 | 72.343 | ||||
| 2024-11-27 | 2024-11-26 | 4 | Samsara BioCapital GP, LLC By Samsara BioCapital, L.P. | NGNE | Common Stock | I | 27,5000 | 2.000 | 55 | 1.717.127 | ||||
| 2024-11-27 | 2024-11-26 | 4 | Samsara BioCapital GP, LLC By Samsara BioCapital, L.P. | NGNE | Common Stock | I | 26,7300 | 15.219 | 407 | 1.715.127 | ||||
| 2024-11-27 | 2024-11-26 | 4 | Samsara BioCapital GP, LLC By Samsara BioCapital, L.P. | NGNE | Common Stock | I | 26,0100 | 10.803 | 281 | 1.699.908 | ||||
| 2024-11-27 | 2024-11-26 | 4 | Samsara BioCapital GP, LLC By Samsara BioCapital, L.P. | NGNE | Common Stock | I | 24,9100 | 20.748 | 517 | 1.689.105 | ||||
| 2024-11-27 | 3 | Samsara BioCapital GP, LLC By Samsara BioCapital, L.P. | NGNE | Common Stock | I | 1.668.357 | ||||||||
| 2024-11-25 | 2024-11-22 | 4 | McMinn Rachel | NGNE | Common Stock | D | 20,4000 | 47.500 | 969 | 1.297.859 | ||||
| 2024-11-25 | 2024-11-22 | 4 | Cvijic Christine Mikail | NGNE | Common Stock | D | 20,4750 | 24.000 | 491 | 76.844 | ||||
| 2024-03-14 | 2024-03-13 | 4 | Cvijic Christine Mikail | NGNE | Common Stock | D | 31.903 | 52.844 | ||||||
| 2024-03-14 | 2024-03-13 | 4 | Cobb Stuart | NGNE | Common Stock | D | 20.391 | 20.391 | ||||||
| 2023-12-26 | 3 | Cvijic Christine Mikail | NGNE | Common Stock | D | 20.941 | ||||||||
| 2023-12-26 | 3 | McMinn Rachel | NGNE | Common Stock | D | 1.250.359 | ||||||||
| 2023-10-10 | 2023-10-05 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Common Stock | I | 535.601 | 1.658.190 | ||||||
| 2023-10-10 | 2023-10-05 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Common Stock | I | 57.049 | 155.874 | ||||||
| 2023-08-17 | 2023-08-17 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Common Stock | I | 0,6928 | 61.134 | 42 | 5.612.949 | ||||
| 2023-08-17 | 2023-08-17 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Common Stock | I | 0,6928 | 5.041 | 3 | 494.133 | ||||
| 2023-08-17 | 2023-08-17 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Common Stock | I | 0,6924 | 93.091 | 64 | 5.551.815 | ||||
| 2023-08-17 | 2023-08-17 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Common Stock | I | 0,6924 | 7.676 | 5 | 489.092 | ||||
| 2023-08-17 | 2023-08-16 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Common Stock | I | 0,6828 | 4.434 | 3 | 5.458.724 | ||||
| 2023-08-17 | 2023-08-16 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Common Stock | I | 0,6828 | 366 | 0 | 481.416 | ||||
| 2023-08-17 | 2023-08-16 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Common Stock | I | 0,6805 | 207.676 | 141 | 5.454.290 | ||||
| 2023-08-17 | 2023-08-16 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Common Stock | I | 0,6805 | 17.124 | 12 | 481.050 | ||||
| 2023-08-17 | 2023-08-15 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Common Stock | I | 0,6650 | 4.342 | 3 | 5.246.614 | ||||
| 2023-08-17 | 2023-08-15 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Common Stock | I | 0,6650 | 358 | 0 | 463.926 | ||||
| 2023-08-17 | 2023-08-15 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Common Stock | I | 0,6308 | 1.740.581 | 1.098 | 5.242.272 | ||||
| 2023-08-17 | 2023-08-15 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Common Stock | I | 0,6308 | 143.519 | 91 | 463.568 | ||||
| 2023-08-14 | 2023-08-11 | 4 | Smith Sean Michael | NLTX | Common Stock | D | 0,6184 | -1.323 | -1 | 21.637 | ||||
| 2023-08-14 | 2023-08-10 | 4 | Smith Sean Michael | NLTX | Common Stock | D | 5.000 | 22.960 | ||||||
| 2023-04-04 | 2023-04-03 | 4 | Patel Priti | NLTX | Common Stock | D | 0,6919 | -3.769 | -3 | 37.313 | ||||
| 2023-04-04 | 2023-03-31 | 4 | Patel Priti | NLTX | Common Stock | D | 10.000 | 41.082 | ||||||
| 2023-02-03 | 2023-02-02 | 4 | Patel Priti | NLTX | Common Stock | D | 0,5972 | -14.380 | -9 | 31.082 | ||||
| 2023-02-03 | 2023-02-01 | 4 | Patel Priti | NLTX | Common Stock | D | 35.000 | 45.462 | ||||||
| 2023-02-03 | 2023-02-02 | 4 | Smith Sean Michael | NLTX | Common Stock | D | 0,5972 | -3.316 | -2 | 15.960 | ||||
| 2023-02-03 | 2023-02-01 | 4 | Smith Sean Michael | NLTX | Common Stock | D | 12.500 | 19.276 | ||||||
| 2022-08-12 | 2022-08-10 | 4 | Smith Sean Michael | NLTX | Common Stock | D | 0,9914 | -1.655 | -2 | 6.776 | ||||
| 2022-08-12 | 2022-08-10 | 4 | Smith Sean Michael | NLTX | Common Stock | D | 5.000 | 8.431 | ||||||
| 2022-05-16 | 2022-05-12 | 4 | SIMPSON TODD E | NLTX | Stock Option (Right to Buy) | D | 1,07 | 25.000 | 25.000 | |||||
| 2022-05-16 | 2022-05-12 | 4 | PALEKAR ROHAN | NLTX | Stock Option (Right to Buy) | D | 1,07 | 25.000 | 25.000 | |||||
| 2022-05-16 | 2022-05-12 | 4 | Lavelle Erin | NLTX | Stock Option (Right to Buy) | D | 1,07 | 25.000 | 25.000 | |||||
| 2022-05-16 | 2022-05-12 | 4 | Noonberg Sarah B. | NLTX | Stock Option (Right to Buy) | D | 1,07 | 25.000 | 25.000 | |||||
| 2022-05-16 | 2022-05-12 | 4 | Babler Martin | NLTX | Stock Option (Right to Buy) | D | 1,07 | 25.000 | 25.000 | |||||
| 2022-05-16 | 2022-05-12 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Non-Qualified Stock Option (right to buy) | I | 1,07 | 25.000 | 25.000 | |||||
| 2022-05-03 | 2022-05-02 | 4 | Patel Priti | NLTX | Common Stock | D | 1,2186 | -5.538 | -7 | 6.462 | ||||
| 2022-05-03 | 2022-04-30 | 4 | Patel Priti | NLTX | Restricted Stock Units | D | 0,00 | 10.000 | 10.000 | |||||
| 2022-05-03 | 2022-04-30 | 4 | Patel Priti | NLTX | Common Stock | D | 10.000 | 12.000 | ||||||
| 2022-03-15 | 2022-03-14 | 4 | Cochener Donna | NLTX | Stock Option (Right to Buy) | D | 1,81 | 400.000 | 400.000 | |||||
| 2022-03-04 | 2022-03-02 | 4 | PALEKAR ROHAN | NLTX | Stock Option (Right to Buy) | D | 2,72 | 50.000 | 50.000 | |||||
| 2022-03-03 | 3 | Smith Sean Michael | NLTX | Common Stock | D | 3.431 | ||||||||
| 2022-03-03 | 2022-03-02 | 4 | Smith Sean Michael | NLTX | Stock Option (Right to Buy) | D | 2,72 | 80.000 | 80.000 | |||||
| 2022-02-14 | 2021-10-26 | 5 | DRACHMAN JONATHAN G | NLTX | Common Stock | I | 75.000 | 100.000 | ||||||
| 2022-02-14 | 2021-10-26 | 5 | DRACHMAN JONATHAN G | NLTX | Common Stock | I | 75.000 | 100.000 | ||||||
| 2022-02-14 | 2021-10-26 | 5 | DRACHMAN JONATHAN G | NLTX | Common Stock | D | -75.000 | 2.198.686 | ||||||
| 2022-02-14 | 2021-10-26 | 5 | DRACHMAN JONATHAN G | NLTX | Common Stock | D | -75.000 | 2.198.686 | ||||||
| 2022-02-02 | 2022-02-01 | 4 | Walkey Carl | NLTX | Restricted Stock Units | D | 0,00 | 55.000 | 55.000 | |||||
| 2022-02-02 | 2022-02-01 | 4 | Patel Priti | NLTX | Restricted Stock Units | D | 0,00 | 70.000 | 70.000 | |||||
| 2022-02-02 | 2022-02-01 | 4 | Ho Robert | NLTX | Restricted Stock Units | D | 0,00 | 70.000 | 70.000 | |||||
| 2021-08-26 | 2021-08-25 | 4 | DRACHMAN JONATHAN G | NLTX | Common Stock | I | 6,4490 | 25.000 | 161 | 25.000 | ||||
| 2021-08-26 | 2021-08-25 | 4 | DRACHMAN JONATHAN G | NLTX | Common Stock | I | 6,4490 | 25.000 | 161 | 25.000 | ||||
| 2021-08-26 | 2021-08-24 | 4 | DRACHMAN JONATHAN G | NLTX | Common Stock | D | 6,1110 | 100.000 | 611 | 2.348.686 | ||||
| 2021-08-05 | 2021-08-03 | 4 | Walkey Carl | NLTX | Stock Option (Right to Buy) | D | 6,80 | 100.000 | 100.000 | |||||
| 2021-08-05 | 2021-08-03 | 4 | Vance Holly | NLTX | Stock Option (Right to Buy) | D | 6,80 | 100.000 | 100.000 | |||||
| 2021-08-05 | 2021-08-03 | 4 | Patel Priti | NLTX | Stock Option (Right to Buy) | D | 6,80 | 50.000 | 50.000 | |||||
| 2021-08-05 | 2021-08-03 | 4 | Ho Robert | NLTX | Stock Option (Right to Buy) | D | 6,80 | 190.000 | 190.000 | |||||
| 2021-08-05 | 2021-08-03 | 4 | DRACHMAN JONATHAN G | NLTX | Stock Option (Right to Buy) | D | 6,80 | 400.000 | 400.000 | |||||
| 2021-06-17 | 2021-06-16 | 4 | Walkey Carl | NLTX | Common Stock | D | 10,1900 | -600 | -6 | 1.352.489 | ||||
| 2021-06-11 | 2021-06-09 | 4 | Walkey Carl | NLTX | Common Stock | D | 10,8246 | -650 | -7 | 1.353.089 | ||||
| 2021-06-09 | 2021-06-08 | 4 | Walkey Carl | NLTX | Common Stock | D | 11,0000 | -600 | -7 | 1.353.739 | ||||
| 2021-06-07 | 2021-06-04 | 4 | Walkey Carl | NLTX | Common Stock | D | 10,0000 | -600 | -6 | 1.354.339 | ||||
| 2021-06-07 | 2021-06-04 | 4 | DRACHMAN JONATHAN G | NLTX | Common Stock | D | 9,6082 | 10.000 | 96 | 2.248.686 | ||||
| 2021-06-07 | 2021-06-03 | 4 | DRACHMAN JONATHAN G | NLTX | Common Stock | D | 9,4818 | 40.000 | 379 | 2.238.686 | ||||
| 2021-05-26 | 2021-05-26 | 4 | Walkey Carl | NLTX | Common Stock | D | 10,0000 | -600 | -6 | 1.354.939 | ||||
| 2021-05-21 | 2021-05-19 | 4 | Walkey Carl | NLTX | Common Stock | D | 10,6300 | -600 | -6 | 1.355.539 | ||||
| 2021-05-13 | 2021-05-11 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Non-Qualified Stock Option (right to buy) | I | 11,40 | 25.000 | 25.000 | |||||
| 2021-05-13 | 2021-05-11 | 4 | Babler Martin | NLTX | Stock Option (Right to Buy) | D | 11,40 | 25.000 | 25.000 | |||||
| 2021-05-13 | 2021-05-11 | 4 | Lavelle Erin M. | NLTX | Stock Option (Right to Buy) | D | 11,40 | 25.000 | 25.000 | |||||
| 2021-05-13 | 2021-05-11 | 4 | Noonberg Sarah B. | NLTX | Stock Option (Right to Buy) | D | 11,40 | 25.000 | 25.000 | |||||
| 2021-05-13 | 2021-05-11 | 4 | Williams Lewis T | NLTX | Stock Option (Right to Buy) | D | 11,40 | 25.000 | 25.000 | |||||
| 2021-05-13 | 2021-05-11 | 4 | SIMPSON TODD E | NLTX | Stock Option (Right to Buy) | D | 11,40 | 25.000 | 25.000 | |||||
| 2021-05-12 | 2021-05-12 | 4 | Walkey Carl | NLTX | Common Stock | D | 11,0900 | -1.200 | -13 | 1.354.762 | ||||
| 2021-05-06 | 2021-05-05 | 4 | Walkey Carl | NLTX | Common Stock | D | 11,3000 | -1.200 | -14 | 1.355.962 | ||||
| 2021-05-04 | 2021-04-30 | 4 | Patel Priti | NLTX | Stock Option (Right to Buy) | D | 12,49 | 475.000 | 475.000 | |||||
| 2021-05-04 | 2021-04-30 | 4 | Patel Priti | NLTX | Restricted Stock Units | D | 0,00 | 20.000 | 20.000 | |||||
| 2021-04-30 | 2021-04-28 | 4 | Walkey Carl | NLTX | Common Stock | D | 12,5800 | -2.400 | -30 | 1.357.162 | ||||
| 2021-04-27 | 2021-04-26 | 4 | Walkey Carl | NLTX | Common Stock | D | 13,0000 | -600 | -8 | 1.359.562 | ||||
| 2021-04-22 | 2021-04-21 | 4 | Walkey Carl | NLTX | Common Stock | D | 11,9800 | -1.800 | -22 | 1.360.162 | ||||
| 2021-04-16 | 2021-04-14 | 4 | Walkey Carl | NLTX | Common Stock | D | 12,2200 | -1.800 | -22 | 1.361.962 | ||||
| 2021-04-08 | 2021-04-07 | 4 | Walkey Carl | NLTX | Common Stock | D | 12,0200 | -1.800 | -22 | 1.363.762 | ||||
| 2021-04-06 | 2021-04-05 | 4 | Walkey Carl | NLTX | Common Stock | D | 13,0000 | -600 | -8 | 1.365.562 | ||||
| 2021-04-02 | 2021-03-31 | 4 | Walkey Carl | NLTX | Common Stock | D | 11,9600 | -1.800 | -22 | 1.366.162 | ||||
| 2021-03-24 | 2021-03-24 | 4 | Walkey Carl | NLTX | Common Stock | D | 11,9533 | -1.800 | -22 | 1.367.962 | ||||
| 2021-03-24 | 2021-03-22 | 4 | Walkey Carl | NLTX | Common Stock | D | 12,0000 | -600 | -7 | 1.369.762 | ||||
| 2021-03-18 | 2021-03-17 | 4 | Walkey Carl | NLTX | Common Stock | D | 11,3600 | -1.200 | -14 | 1.370.362 | ||||
| 2021-03-18 | 2021-03-17 | 4 | Ho Robert | NLTX | Common Stock | D | 11,0137 | -6.497 | -72 | 21.503 | ||||
| 2021-03-18 | 2021-03-16 | 4 | Ho Robert | NLTX | Restricted Stock Units | D | 0,00 | 25.000 | 50.000 | |||||
| 2021-03-18 | 2021-03-16 | 4 | Ho Robert | NLTX | Common Stock | D | 25.000 | 28.000 | ||||||
| 2021-03-11 | 2021-03-10 | 4 | Walkey Carl | NLTX | Common Stock | D | 11,9667 | -1.800 | -22 | 1.371.562 | ||||
| 2021-03-04 | 2021-03-03 | 4 | Walkey Carl | NLTX | Common Stock | D | 11,8667 | -1.800 | -21 | 1.373.362 | ||||
| 2021-02-25 | 2021-02-25 | 4 | Walkey Carl | NLTX | Common Stock | D | 13,0000 | -600 | -8 | 1.375.162 | ||||
| 2021-02-25 | 2021-02-24 | 4 | Walkey Carl | NLTX | Common Stock | D | 12,1400 | -1.800 | -22 | 1.375.762 | ||||
| 2021-02-18 | 2021-02-17 | 4 | Walkey Carl | NLTX | Common Stock | D | 12,7000 | -2.400 | -30 | 1.377.562 | ||||
| 2021-02-12 | 2021-02-10 | 4 | Walkey Carl | NLTX | Common Stock | D | 14,2000 | -3.000 | -43 | 1.379.962 | ||||
| 2021-02-09 | 2021-02-05 | 4 | Walkey Carl | NLTX | Common Stock | D | 14,0000 | -600 | -8 | 1.382.962 | ||||
| 2021-02-05 | 2021-02-03 | 4 | Walkey Carl | NLTX | Common Stock | D | 13,2300 | -2.400 | -32 | 1.383.562 | ||||
| 2021-02-02 | 2021-01-30 | 4 | Walkey Carl | NLTX | Stock Option (Right to Buy) | D | 12,60 | 45.000 | 45.000 | |||||
| 2021-02-02 | 3 | Walkey Carl | NLTX | Common Stock | D | 1.385.962 | ||||||||
| 2020-12-23 | 2020-07-07 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Pre-Funded Warrants | I | 518.555 | 10.283.888 | ||||||
| 2020-12-23 | 2020-07-07 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Pre-Funded Warrants | I | 38.974 | 1.199.122 | ||||||
| 2020-12-23 | 2020-07-07 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Common Stock | I | 15,2500 | 394.360 | 6.014 | 3.501.691 | ||||
| 2020-12-23 | 2020-07-07 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Common Stock | I | 15,2500 | 29.640 | 452 | 320.049 | ||||
| 2020-10-20 | 2020-10-19 | 4 | Vance Holly | NLTX | Stock Option (Right to Buy) | D | 12,30 | 220.000 | 220.000 | |||||
| 2020-09-10 | 2020-09-08 | 4 | Babler Martin | NLTX | Stock Option (Right to Buy) | D | 12,25 | 50.000 | 50.000 | |||||
| 2020-08-12 | 2020-08-10 | 4 | DRACHMAN JONATHAN G | NLTX | Stock Option (Right to Buy) | D | 12,00 | 420.000 | 420.000 | |||||
| 2020-08-12 | 2020-08-10 | 4 | Ho Robert | NLTX | Stock Option (Right to Buy) | D | 12,00 | 90.000 | 90.000 | |||||
| 2020-06-02 | 2020-06-01 | 4 | Lavelle Erin M. | NLTX | Stock Option (Right to Buy) | D | 13,58 | 50.000 | 50.000 | |||||
| 2020-05-07 | 2020-05-05 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Non-Qualified Stock Option (right to buy) | I | 12,84 | 25.000 | 25.000 | |||||
| 2020-05-07 | 2020-05-05 | 4 | Nolan Sean P. | NLTX | Stock Option (Right to Buy) | D | 12,84 | 25.000 | 25.000 | |||||
| 2020-05-07 | 2020-05-05 | 4 | Noonberg Sarah B. | NLTX | Stock Option (Right to Buy) | D | 12,84 | 25.000 | 25.000 | |||||
| 2020-05-07 | 2020-05-05 | 4 | SIMPSON TODD E | NLTX | Stock Option (Right to Buy) | D | 12,84 | 25.000 | 25.000 | |||||
| 2020-05-07 | 2020-05-05 | 4 | Williams Lewis T | NLTX | Stock Option (Right to Buy) | D | 12,84 | 25.000 | 25.000 | |||||
| 2020-04-06 | 2020-04-02 | 4 | Redmile Group, LLC | NLTX | Common Stock | I | 11,8200 | -100 | -1 | 4.041.211 | ||||
| 2020-04-06 | 2020-04-02 | 4 | Redmile Group, LLC | NLTX | Common Stock | I | 11,3039 | -9.734 | -110 | 4.041.311 | ||||
| 2020-04-06 | 2020-04-02 | 4 | Redmile Group, LLC | NLTX | Common Stock | I | 11,8506 | 1.000 | 12 | 4.051.045 | ||||
| 2020-04-06 | 2020-04-02 | 4 | Redmile Group, LLC | NLTX | Common Stock | I | 11,3605 | 38.300 | 435 | 4.050.045 | ||||
| 2020-04-06 | 2020-04-01 | 4 | Redmile Group, LLC | NLTX | Common Stock | I | 11,8650 | -200 | -2 | 4.011.745 | ||||
| 2020-04-06 | 2020-04-01 | 4 | Redmile Group, LLC | NLTX | Common Stock | I | 11,0616 | -9.634 | -107 | 4.011.945 | ||||
| 2020-04-06 | 2020-04-01 | 4 | Redmile Group, LLC | NLTX | Common Stock | I | 11,6517 | 9.000 | 105 | 4.021.579 | ||||
| 2020-04-06 | 2020-04-01 | 4 | Redmile Group, LLC | NLTX | Common Stock | I | 10,9482 | 33.500 | 367 | 4.012.579 | ||||
| 2020-04-06 | 2020-03-31 | 4 | Redmile Group, LLC | NLTX | Common Stock | I | 10,7079 | 7.500 | 80 | 3.979.079 | ||||
| 2020-04-06 | 2020-03-31 | 4 | Redmile Group, LLC | NLTX | Common Stock | I | 10,1813 | 22.500 | 229 | 3.971.579 | ||||
| 2020-04-06 | 2020-03-30 | 4 | Redmile Group, LLC | NLTX | Common Stock | I | 10,2744 | 2.700 | 28 | 3.949.079 | ||||
| 2020-04-06 | 2020-03-30 | 4 | Redmile Group, LLC | NLTX | Common Stock | I | 9,9050 | 29.800 | 295 | 3.946.379 | ||||
| 2020-04-06 | 2020-03-27 | 4 | Redmile Group, LLC | NLTX | Common Stock | I | 9,2079 | 50.000 | 460 | 3.916.579 | ||||
| 2020-04-06 | 3 | Green Jeremy | NLTX | Common Stock | I | 7.733.158 | ||||||||
| 2020-04-06 | 3 | Green Jeremy | NLTX | Common Stock | I | 7.733.158 | ||||||||
| 2020-04-06 | 3 | Green Jeremy | NLTX | Common Stock | I | 7.733.158 | ||||||||
| 2020-04-06 | 3 | Green Jeremy | NLTX | Common Stock | I | 7.733.158 | ||||||||
| 2020-03-16 | 3 | Ho Robert | NLTX | Common Stock | D | 6.000 | ||||||||
| 2020-03-16 | 3 | Ho Robert | NLTX | Common Stock | D | 6.000 | ||||||||
| 2020-03-16 | 3 | Ho Robert | NLTX | Common Stock | D | 6.000 | ||||||||
| 2020-03-16 | 2020-03-16 | 4 | Ho Robert | NLTX | Stock Option (Right to Buy) | D | 6,44 | 200.000 | 200.000 | |||||
| 2020-03-16 | 2020-03-16 | 4 | Ho Robert | NLTX | Restricted Stock Units | D | 0,00 | 75.000 | 75.000 | |||||
| 2019-12-20 | 2019-12-20 | 4 | DRACHMAN JONATHAN G | NLTX | Common Stock | D | 8,4000 | 119.047 | 1.000 | 2.198.686 | ||||
| 2019-12-20 | 2019-11-12 | 4 | DRACHMAN JONATHAN G | NLTX | Common Stock | D | 1.261.600 | 2.079.639 | ||||||
| 2019-12-20 | 2019-11-12 | 4 | DRACHMAN JONATHAN G | NLTX | Series A Preferred Stock | D | -12.616 | 0 | ||||||
| 2019-12-20 | 2019-12-20 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Pre-funded Warrants | I | 9.765.333 | 9.765.333 | ||||||
| 2019-12-20 | 2019-12-20 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Pre-funded Warrants | I | 1.160.148 | 1.161.048 | ||||||
| 2019-12-20 | 2019-12-20 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Common Stock | I | -9.765.333 | 3.107.331 | ||||||
| 2019-12-20 | 2019-12-20 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Common Stock | I | -1.160.148 | 290.409 | ||||||
| 2019-12-20 | 2019-12-20 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Common Stock | I | 8,4000 | 2.767.505 | 23.247 | 12.872.664 | ||||
| 2019-12-20 | 2019-12-20 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Common Stock | I | 8,4000 | 250.037 | 2.100 | 1.450.557 | ||||
| 2019-10-15 | 2019-10-10 | 4 | BAKER BROS. ADVISORS LP See Footnotes | NLTX | Non-Qualified Stock Option (right to buy) | I | 2,82 | 22.000 | 22.000 | |||||
| 2019-10-15 | 2019-10-10 | 4 | Williams Lewis T | NLTX | Stock Option (right to buy) | D | 2,82 | 22.000 | 22.000 | |||||
| 2019-10-15 | 2019-10-10 | 4 | Nolan Sean P. | NLTX | Stock Option (right to buy) | D | 2,82 | 22.000 | 22.000 | |||||
| 2019-10-15 | 2019-10-10 | 4 | Noonberg Sarah B. | NLTX | Stock Option (right to buy) | D | 2,82 | 22.000 | 22.000 | |||||
| 2019-10-15 | 2019-10-10 | 4 | SIMPSON TODD E | NLTX | Stock Option (right to buy) | D | 2,82 | 22.000 | 22.000 | |||||
| 2019-09-13 | 2019-08-08 | 4/A | DRACHMAN JONATHAN G | NLTX | Series A Preferred Stock | D | 12.616 | 12.616 | ||||||
| 2019-09-13 | 2019-08-08 | 4/A | DRACHMAN JONATHAN G | NLTX | Common Stock | D | 568.039 | 568.039 | ||||||
| 2019-09-11 | 2019-09-11 | 4 | DRACHMAN JONATHAN G | NLTX | Common Stock | D | 3,2975 | 136.436 | 450 | 584.428 | ||||
| 2019-09-11 | 2019-09-10 | 4 | DRACHMAN JONATHAN G | NLTX | Common Stock | D | 3,0834 | 36.742 | 113 | 447.992 | ||||
| 2019-09-11 | 2019-09-09 | 4 | DRACHMAN JONATHAN G | NLTX | Common Stock | D | 2,8450 | 76.822 | 219 | 411.250 | ||||
| 2019-09-04 | 2019-08-31 | 4 | DRACHMAN JONATHAN G | NLTX | Stock Option (Right to Buy) | D | 2,80 | 1.650.000 | 1.650.000 | |||||
| 2019-08-12 | 2019-08-08 | 4 | DRACHMAN JONATHAN G | NLTX | Series A Preferred Stock | D | 7.428 | 7.428 | ||||||
| 2019-08-12 | 2019-08-08 | 4 | DRACHMAN JONATHAN G | NLTX | Common Stock | D | 334.428 | 334.428 | ||||||
| 2019-08-08 | 2019-08-07 | 4 | BAKER BROS. ADVISORS LP See footnotes | AQXP | Common Stock | I | 3,1529 | 50.436 | 159 | 10.105.159 | ||||
| 2019-08-08 | 2019-08-07 | 4 | BAKER BROS. ADVISORS LP See footnotes | AQXP | Common Stock | I | 3,1529 | 4.564 | 14 | 1.200.520 | ||||
| 2019-08-08 | 2019-08-07 | 4 | BAKER BROS. ADVISORS LP See footnotes | AQXP | Common Stock | I | 3,0244 | 209.382 | 633 | 10.054.723 | ||||
| 2019-08-08 | 2019-08-07 | 4 | BAKER BROS. ADVISORS LP See footnotes | AQXP | Common Stock | I | 3,0244 | 18.943 | 57 | 1.195.956 | ||||
| 2019-08-08 | 2019-08-07 | 4 | BAKER BROS. ADVISORS LP See footnotes | AQXP | Common Stock | I | 2,9576 | 5.869 | 17 | 9.845.341 | ||||
| 2019-08-08 | 2019-08-07 | 4 | BAKER BROS. ADVISORS LP See footnotes | AQXP | Common Stock | I | 2,9576 | 531 | 2 | 1.177.013 | ||||
| 2019-08-08 | 2019-08-06 | 4 | BAKER BROS. ADVISORS LP See footnotes | AQXP | Common Stock | I | 2,8469 | 65.568 | 187 | 9.839.472 | ||||
| 2019-08-08 | 2019-08-06 | 4 | BAKER BROS. ADVISORS LP See footnotes | AQXP | Common Stock | I | 2,8469 | 5.932 | 17 | 1.176.482 | ||||
| 2019-08-08 | 2019-08-06 | 4 | BAKER BROS. ADVISORS LP See footnotes | AQXP | Common Stock | I | 2,8328 | 9.445 | 27 | 9.773.904 | ||||
| 2019-08-08 | 2019-08-06 | 4 | BAKER BROS. ADVISORS LP See footnotes | AQXP | Common Stock | I | 2,8328 | 855 | 2 | 1.170.550 | ||||
| 2018-08-09 | 2018-08-07 | 4 | Alam Kamran | AQXP | Stock Option (Right to Buy) | D | 3,07 | 195.000 | 195.000 | |||||
| 2018-08-09 | 2018-08-07 | 4 | MacKenzie Lloyd | AQXP | Stock Option (Right to Buy) | D | 3,07 | 145.000 | 145.000 | |||||
| 2018-08-09 | 2018-08-07 | 4 | McCloskey Shelley | AQXP | Stock Option (Right to Buy) | D | 3,07 | 75.000 | 75.000 | |||||
| 2018-08-09 | 2018-08-07 | 4 | Main David | AQXP | Stock Option (Right to Buy) | D | 3,07 | 415.000 | 415.000 | |||||
| 2018-05-16 | 2018-05-14 | 4 | LEVITT DANIEL J | AQXP | Stock Option (Right to Buy) | D | 10,56 | -3.906 | 0 | |||||
| 2018-05-16 | 2018-05-14 | 4 | LEVITT DANIEL J | AQXP | Common Stock | D | 12,6700 | -3.906 | -49 | 0 | ||||
| 2018-05-16 | 2018-05-14 | 4 | LEVITT DANIEL J | AQXP | Common Stock | D | 10,5600 | 3.906 | 41 | 3.906 | ||||
| 2018-05-09 | 2018-05-07 | 4 | Pelzer Robert | AQXP | Stock Option (Right to Buy) | D | 13,10 | 15.000 | 15.000 | |||||
| 2018-05-09 | 2018-05-07 | 4 | SIMPSON TODD E | AQXP | Stock Option (Right to Buy) | D | 13,10 | 15.000 | 15.000 | |||||
| 2018-05-09 | 2018-05-07 | 4 | LEVITT DANIEL J | AQXP | Stock Option (Right to Buy) | D | 13,10 | 15.000 | 15.000 | |||||
| 2018-05-09 | 2018-05-07 | 4 | Nolan Sean P. | AQXP | Stock Option (Right to Buy) | D | 13,10 | 15.000 | 15.000 | |||||
| 2018-05-09 | 2018-05-07 | 4 | Bridger Gary | AQXP | Stock Option (Right to Buy) | D | 13,10 | 15.000 | 15.000 | |||||
| 2018-05-09 | 2018-05-07 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Non-Qualified Stock Option (right to buy) | I | 13,10 | 30.000 | 30.000 | |||||
| 2018-03-19 | 2018-03-15 | 4 | MacKenzie Lloyd | AQXP | Stock Option (Right to Buy) | D | 10,56 | -1.302 | 0 | |||||
| 2018-03-19 | 2018-03-15 | 4 | MacKenzie Lloyd | AQXP | Common Stock | D | 14,6304 | -1.302 | -19 | 0 | ||||
| 2018-03-19 | 2018-03-15 | 4 | MacKenzie Lloyd | AQXP | Common Stock | D | 10,5600 | 1.302 | 14 | 1.302 | ||||
| 2018-03-13 | 2018-03-09 | 4 | Troupin Barbara | AQXP | Stock Option (Right to Buy) | D | 16,55 | 75.000 | 75.000 | |||||
| 2018-03-13 | 2018-03-09 | 4 | Alam Kamran | AQXP | Stock Option (Right to Buy) | D | 16,55 | 75.000 | 75.000 | |||||
| 2018-03-13 | 2018-03-09 | 4 | Jenkins Abigail | AQXP | Stock Option (Right to Buy) | D | 16,55 | 75.000 | 75.000 | |||||
| 2018-03-13 | 2018-03-09 | 4 | MacKenzie Lloyd | AQXP | Stock Option (Right to Buy) | D | 16,55 | 75.000 | 75.000 | |||||
| 2018-03-13 | 2018-03-09 | 4 | Main David | AQXP | Stock Option (Right to Buy) | D | 16,55 | 225.000 | 225.000 | |||||
| 2018-03-13 | 2018-03-09 | 4 | McCloskey Shelley | AQXP | Stock Option (Right to Buy) | D | 16,55 | 45.000 | 45.000 | |||||
| 2017-06-05 | 2017-06-05 | 4 | Main David | AQXP | Stock Option (Right to Buy) | D | 9,60 | -3.625 | 0 | |||||
| 2017-06-05 | 2017-06-05 | 4 | Main David | AQXP | Common Stock | D | 13,1575 | -3.625 | -48 | 71.530 | ||||
| 2017-06-05 | 2017-06-05 | 4 | Main David | AQXP | Common Stock | D | 9,6000 | 3.625 | 35 | 75.155 | ||||
| 2017-06-05 | 2017-06-02 | 4 | Main David | AQXP | Stock Option (Right to Buy( | D | 9,60 | -6.000 | 3.625 | |||||
| 2017-06-05 | 2017-06-02 | 4 | Main David | AQXP | Common Stock | D | 13,5933 | -6.000 | -82 | 71.530 | ||||
| 2017-06-05 | 2017-06-02 | 4 | Main David | AQXP | Common Stock | D | 9,6000 | 6.000 | 58 | 77.530 | ||||
| 2017-06-05 | 2017-06-01 | 4 | Main David | AQXP | Stock Option (Right to Buy) | D | 9,60 | -6.000 | 9.625 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Main David | AQXP | Common Stock | D | 12,9980 | -6.000 | -78 | 71.530 | ||||
| 2017-06-05 | 2017-06-01 | 4 | Main David | AQXP | Common Stock | D | 9,6000 | 6.000 | 58 | 77.530 | ||||
| 2017-05-10 | 2017-05-08 | 4 | SIMPSON TODD E | AQXP | Stock Option (Right to Buy) | D | 13,74 | 9.000 | 9.000 | |||||
| 2017-05-10 | 2017-05-08 | 4 | Nolan Sean P. | AQXP | Stock Option (Right to Buy) | D | 13,74 | 9.000 | 9.000 | |||||
| 2017-05-10 | 2017-05-08 | 4 | Pelzer Robert | AQXP | Stock Option (Right to Buy) | D | 13,74 | 9.000 | 9.000 | |||||
| 2017-05-10 | 2017-05-08 | 4 | LEVITT DANIEL J | AQXP | Stock Option (Right to Buy) | D | 13,74 | 9.000 | 9.000 | |||||
| 2017-05-10 | 2017-05-08 | 4 | Bridger Gary | AQXP | Stock Option (Right to Buy) | D | 13,74 | 9.000 | 9.000 | |||||
| 2017-05-09 | 2017-05-08 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Non-Qualified Stock Option (right to buy) | I | 13,74 | 36.000 | 36.000 | |||||
| 2017-03-27 | 3 | Neu Kelvin | AQXP | Common Stock | D | 72 | ||||||||
| 2017-03-27 | 3 | Neu Kelvin | AQXP | Common Stock | D | 72 | ||||||||
| 2017-03-10 | 2017-03-08 | 4 | McCloskey Shelley | AQXP | Stock Option (Right to Buy) | D | 17,35 | 30.000 | 30.000 | |||||
| 2017-03-10 | 2017-03-08 | 4 | Mitchell David Chilton | AQXP | Stock Option (Right to Buy) | D | 17,35 | 25.000 | 25.000 | |||||
| 2017-03-10 | 2017-03-08 | 4 | Troupin Barbara | AQXP | Stock Option (Right to Buy) | D | 17,35 | 40.000 | 40.000 | |||||
| 2017-03-10 | 2017-03-08 | 4 | MacKenzie Lloyd | AQXP | Stock Option (Right to Buy) | D | 17,35 | 50.000 | 50.000 | |||||
| 2017-03-10 | 2017-03-08 | 4 | Main David | AQXP | Stock Option (Right to Buy) | D | 17,35 | 185.000 | 185.000 | |||||
| 2017-03-10 | 2017-03-08 | 4 | Alam Kamran | AQXP | Stock Option (Right to Buy) | D | 17,35 | 80.000 | 80.000 | |||||
| 2017-03-10 | 2017-03-08 | 4 | Jenkins Abigail | AQXP | Stock Option (Right to Buy) | D | 17,35 | 80.000 | 80.000 | |||||
| 2017-02-14 | 2016-01-10 | 5 | McCloskey Shelley | AQXP | Stock Option (Right to Buy) | D | 10,09 | 35.000 | 35.000 | |||||
| 2017-01-09 | 2017-01-09 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 17,7600 | 32.051 | 569 | 9.764.459 | ||||
| 2017-01-09 | 2017-01-09 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 17,7600 | 3.389 | 60 | 1.169.695 | ||||
| 2017-01-09 | 2017-01-09 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 17,5996 | 235.169 | 4.139 | 9.732.408 | ||||
| 2017-01-09 | 2017-01-09 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 17,5996 | 24.871 | 438 | 1.166.306 | ||||
| 2017-01-09 | 2017-01-09 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 16,3053 | 35.360 | 577 | 9.497.239 | ||||
| 2017-01-09 | 2017-01-09 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 16,3053 | 3.739 | 61 | 1.141.435 | ||||
| 2017-01-09 | 2017-01-09 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 15,6226 | 5.006 | 78 | 9.461.879 | ||||
| 2017-01-09 | 2017-01-09 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 15,6226 | 529 | 8 | 1.137.696 | ||||
| 2017-01-09 | 2017-01-09 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 15,1300 | 15.148 | 229 | 9.456.873 | ||||
| 2017-01-09 | 2017-01-09 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 15,1300 | 1.602 | 24 | 1.137.167 | ||||
| 2017-01-09 | 2017-01-09 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 16,1970 | 9.143 | 148 | 9.441.725 | ||||
| 2017-01-09 | 2017-01-09 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 16,1970 | 967 | 16 | 1.135.565 | ||||
| 2017-01-09 | 2017-01-09 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 15,3475 | 8.671 | 133 | 9.432.582 | ||||
| 2017-01-09 | 2017-01-09 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 15,3475 | 917 | 14 | 1.134.598 | ||||
| 2017-01-09 | 2017-01-09 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 16,8533 | 2.442 | 41 | 9.423.911 | ||||
| 2017-01-09 | 2017-01-09 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 16,8533 | 258 | 4 | 1.133.681 | ||||
| 2017-01-09 | 2017-01-09 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 15,3210 | 11.305 | 173 | 9.421.469 | ||||
| 2017-01-09 | 2017-01-09 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 15,3210 | 1.195 | 18 | 1.133.423 | ||||
| 2017-01-09 | 2017-01-09 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 16,7395 | 5.697 | 95 | 9.410.164 | ||||
| 2017-01-09 | 2017-01-09 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 16,7395 | 603 | 10 | 1.132.228 | ||||
| 2016-11-10 | 2016-11-08 | 4 | Troupin Barbara | AQXP | Stock Option (Right to Buy) | D | 11,77 | 50.000 | 50.000 | |||||
| 2016-10-06 | 3 | Troupin Barbara | AQXP | No securities are benefically owned | D | 0 | ||||||||
| 2016-09-21 | 2016-09-20 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 13,1497 | 12.550 | 165 | 1.131.625 | ||||
| 2016-09-21 | 2016-09-20 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 12,2500 | 2.476.348 | 30.335 | 9.404.467 | ||||
| 2016-09-21 | 2016-09-20 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 12,2500 | 294.707 | 3.610 | 1.119.075 | ||||
| 2016-08-05 | 2016-08-03 | 4 | Jenkins Abigail | AQXP | Stock Option (Right to Buy) | D | 8,97 | 50.000 | 50.000 | |||||
| 2016-06-15 | 3 | Jenkins Abigail | AQXP | No securities are beneficially owned | D | 0 | ||||||||
| 2016-05-11 | 2016-05-09 | 4 | LEVITT DANIEL J | AQXP | Stock Option (Right to Buy) | D | 7,73 | 7.500 | 7.500 | |||||
| 2016-05-11 | 2016-05-09 | 4 | SIMPSON TODD E | AQXP | Stock Option (Right to Buy) | D | 7,73 | 7.500 | 7.500 | |||||
| 2016-05-11 | 2016-05-09 | 4 | Pelzer Robert | AQXP | Stock Option (Right to Buy) | D | 7,73 | 7.500 | 7.500 | |||||
| 2016-05-11 | 2016-05-09 | 4 | Nolan Sean P. | AQXP | Stock Option (Right to Buy) | D | 7,73 | 7.500 | 7.500 | |||||
| 2016-05-11 | 2016-05-09 | 4 | Bridger Gary | AQXP | Stock Option (Right to Buy) | D | 7,73 | 7.500 | 7.500 | |||||
| 2016-03-16 | 2016-03-16 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,1560 | 128.975 | 1.052 | 6.928.119 | ||||
| 2016-03-16 | 2016-03-16 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,1560 | 14.046 | 115 | 824.368 | ||||
| 2016-03-16 | 2016-03-16 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 7,9084 | 185.413 | 1.466 | 6.799.144 | ||||
| 2016-03-16 | 2016-03-16 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 7,9084 | 20.192 | 160 | 810.322 | ||||
| 2016-03-16 | 2016-03-16 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 7,6993 | 11.840 | 91 | 6.613.731 | ||||
| 2016-03-16 | 2016-03-16 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 7,6993 | 1.289 | 10 | 790.130 | ||||
| 2016-03-16 | 2016-03-15 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,0257 | 68.132 | 547 | 6.601.891 | ||||
| 2016-03-16 | 2016-03-15 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,0257 | 7.420 | 60 | 788.841 | ||||
| 2016-03-16 | 2016-03-15 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 7,8786 | 30.986 | 244 | 6.533.759 | ||||
| 2016-03-16 | 2016-03-15 | 4 | BAKER BROS. ADVISORS LP | AQXP | Common Stock | I | 7,8786 | 3.374 | 27 | 781.421 | ||||
| 2016-03-14 | 2016-03-10 | 4 | SHREWSBURY STEPHEN B | AQXP | Stock Option (Right to Buy) | D | 8,08 | 35.000 | 35.000 | |||||
| 2016-03-14 | 2016-03-10 | 4 | Main David | AQXP | Stock Option (Right to Buy) | D | 8,08 | 120.000 | 120.000 | |||||
| 2016-03-14 | 2016-03-10 | 4 | Alam Kamran | AQXP | Stock Option (Right to Buy) | D | 8,08 | 40.000 | 40.000 | |||||
| 2016-03-14 | 2016-03-10 | 4 | MacKenzie Lloyd | AQXP | Stock Option (Right to Buy) | D | 8,08 | 35.000 | 35.000 | |||||
| 2016-03-14 | 2016-03-10 | 4 | Mitchell David Chilton | AQXP | Stock Option (Right to Buy) | D | 8,08 | 25.000 | 25.000 | |||||
| 2016-01-26 | 2016-01-26 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 10,9960 | 3.581 | 39 | 6.502.773 | ||||
| 2016-01-26 | 2016-01-26 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 10,9960 | 395 | 4 | 778.047 | ||||
| 2016-01-26 | 2016-01-26 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 10,8033 | 66.345 | 717 | 6.499.192 | ||||
| 2016-01-26 | 2016-01-26 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 10,8033 | 7.318 | 79 | 777.652 | ||||
| 2016-01-26 | 2016-01-25 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 11,2043 | 2.522 | 28 | 6.432.847 | ||||
| 2016-01-26 | 2016-01-25 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 11,2043 | 278 | 3 | 770.334 | ||||
| 2016-01-26 | 2016-01-25 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 10,9755 | 4.503 | 49 | 6.430.325 | ||||
| 2016-01-26 | 2016-01-25 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 10,9755 | 497 | 5 | 770.056 | ||||
| 2016-01-26 | 2016-01-25 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 11,2326 | 2.833 | 32 | 6.425.822 | ||||
| 2016-01-26 | 2016-01-25 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 11,2326 | 312 | 4 | 769.559 | ||||
| 2016-01-26 | 2016-01-22 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 10,6908 | 25.650 | 274 | 6.422.989 | ||||
| 2016-01-26 | 2016-01-22 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 10,6908 | 2.810 | 30 | 769.247 | ||||
| 2016-01-26 | 2016-01-22 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 10,6000 | 156 | 2 | 6.397.339 | ||||
| 2016-01-26 | 2016-01-22 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 10,6000 | 17 | 0 | 766.437 | ||||
| 2016-01-26 | 2016-01-22 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 10,6937 | 4.021 | 43 | 6.397.183 | ||||
| 2016-01-26 | 2016-01-22 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 10,6937 | 440 | 5 | 766.420 | ||||
| 2016-01-26 | 2016-01-22 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 10,7814 | 17.221 | 186 | 6.393.162 | ||||
| 2016-01-26 | 2016-01-22 | 4 | BAKER BROS. ADVISORS LP | AQXP | Common Stock | I | 10,7814 | 1.887 | 20 | 765.980 | ||||
| 2016-01-20 | 2016-01-20 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,9000 | 1.734 | 15 | 6.375.941 | ||||
| 2016-01-20 | 2016-01-20 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,9000 | 190 | 2 | 764.093 | ||||
| 2016-01-20 | 2016-01-20 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,9572 | 27.996 | 251 | 6.374.207 | ||||
| 2016-01-20 | 2016-01-20 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,9572 | 3.067 | 27 | 763.903 | ||||
| 2016-01-20 | 2016-01-20 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,9559 | 13.789 | 123 | 6.346.211 | ||||
| 2016-01-20 | 2016-01-20 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,9559 | 1.511 | 14 | 760.836 | ||||
| 2016-01-20 | 2016-01-20 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 9,8852 | 57.453 | 568 | 6.332.422 | ||||
| 2016-01-20 | 2016-01-20 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 9,8852 | 6.294 | 62 | 759.325 | ||||
| 2016-01-20 | 2016-01-19 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 9,1537 | 14.313 | 131 | 6.274.969 | ||||
| 2016-01-20 | 2016-01-19 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 9,1537 | 1.568 | 14 | 753.031 | ||||
| 2016-01-20 | 2016-01-19 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 9,2149 | 10.123 | 93 | 6.260.656 | ||||
| 2016-01-20 | 2016-01-19 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 9,2149 | 1.109 | 10 | 751.463 | ||||
| 2016-01-20 | 2016-01-19 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 9,0757 | 45.903 | 417 | 6.250.533 | ||||
| 2016-01-20 | 2016-01-19 | 4 | BAKER BROS. ADVISORS LP | AQXP | Common Stock | I | 9,0757 | 5.029 | 46 | 750.354 | ||||
| 2016-01-15 | 2016-01-15 | 4/A | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,5591 | 47.193 | 404 | 6.204.630 | ||||
| 2016-01-15 | 2016-01-15 | 4/A | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,5591 | 5.196 | 44 | 745.325 | ||||
| 2016-01-15 | 2016-01-15 | 4/A | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,9529 | 4.949 | 44 | 6.157.437 | ||||
| 2016-01-15 | 2016-01-15 | 4/A | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,9529 | 545 | 5 | 740.129 | ||||
| 2016-01-15 | 2016-01-15 | 4/A | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,8249 | 3.279 | 29 | 6.152.488 | ||||
| 2016-01-15 | 2016-01-15 | 4/A | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,8249 | 361 | 3 | 739.584 | ||||
| 2016-01-15 | 2016-01-15 | 4/A | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,0999 | 20.851 | 169 | 6.149.209 | ||||
| 2016-01-15 | 2016-01-15 | 4/A | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,0999 | 2.296 | 19 | 739.223 | ||||
| 2016-01-15 | 2016-01-14 | 4/A | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,0764 | 2.998 | 24 | 6.128.358 | ||||
| 2016-01-15 | 2016-01-14 | 4/A | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,0764 | 330 | 3 | 736.927 | ||||
| 2016-01-15 | 2016-01-14 | 4/A | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 7,9110 | 12.706 | 101 | 6.125.360 | ||||
| 2016-01-15 | 2016-01-14 | 4/A | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 7,9110 | 1.399 | 11 | 736.597 | ||||
| 2016-01-15 | 2016-01-14 | 4/A | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,1717 | 90.550 | 740 | 6.112.654 | ||||
| 2016-01-15 | 2016-01-14 | 4/A | BAKER BROS. ADVISORS LP | AQXP | Common Stock | I | 8,1717 | 9.970 | 81 | 735.198 | ||||
| 2016-01-15 | 2016-01-15 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,5591 | 47.193 | 404 | 6.204.630 | ||||
| 2016-01-15 | 2016-01-15 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,5591 | 5.196 | 44 | 745.325 | ||||
| 2016-01-15 | 2016-01-15 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,9529 | 4.949 | 44 | 6.157.437 | ||||
| 2016-01-15 | 2016-01-15 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,9529 | 545 | 5 | 740.129 | ||||
| 2016-01-15 | 2016-01-15 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,8249 | 3.279 | 29 | 6.152.488 | ||||
| 2016-01-15 | 2016-01-15 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,8249 | 361 | 3 | 739.584 | ||||
| 2016-01-15 | 2016-01-15 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,0999 | 20.851 | 169 | 6.149.209 | ||||
| 2016-01-15 | 2016-01-15 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,0999 | 2.296 | 19 | 739.223 | ||||
| 2016-01-15 | 2016-01-14 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,0764 | 2.998 | 24 | 6.128.358 | ||||
| 2016-01-15 | 2016-01-14 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,0764 | 330 | 3 | 736.927 | ||||
| 2016-01-15 | 2016-01-14 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 7,9110 | 12.706 | 101 | 6.125.360 | ||||
| 2016-01-15 | 2016-01-14 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 7,9110 | 1.399 | 11 | 736.597 | ||||
| 2016-01-15 | 2016-01-14 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 8,1717 | 90.550 | 740 | 6.112.654 | ||||
| 2016-01-15 | 2016-01-14 | 4 | BAKER BROS. ADVISORS LP | AQXP | Common Stock | I | 8,1717 | 9.970 | 81 | 735.198 | ||||
| 2015-12-23 | 3 | McCloskey Shelley | AQXP | No securities are beneficially owned | D | 0 | ||||||||
| 2015-11-03 | 2015-10-31 | 4 | Bridger Gary | AQXP | Common Stock | I | -1.543.989 | 0 | ||||||
| 2015-09-11 | 2015-09-10 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AQXP | Common Stock | I | 15,5000 | 2.213.469 | 34.309 | 6.022.104 | ||||
| 2015-09-11 | 2015-09-10 | 4 | BAKER BROS. ADVISORS LP | AQXP | Common Stock | I | 15,5000 | 266.563 | 4.132 | 725.228 | ||||
| 2015-08-26 | 2015-08-24 | 4 | Mitchell David Chilton By spouse | AQXP | Common Stock | I | 17,8100 | 3.575 | 64 | 3.575 | ||||
| 2015-08-14 | 2015-08-12 | 4 | MacKenzie Lloyd | AQXP | Stock Option (Right to Buy) | D | 5,76 | 28.075 | 1.872 | |||||
| 2015-08-14 | 2015-08-12 | 4 | MacKenzie Lloyd | AQXP | Stock Option (Right to Buy) | D | 5,76 | 7.812 | 0 | |||||
| 2015-08-14 | 2015-08-12 | 4 | MacKenzie Lloyd | AQXP | Common Stock | D | 18,6700 | -35.887 | -670 | 0 | ||||
| 2015-08-14 | 2015-08-12 | 4 | MacKenzie Lloyd | AQXP | Common Stock | D | 5,7600 | 28.075 | 162 | 35.887 | ||||
| 2015-08-14 | 2015-08-12 | 4 | MacKenzie Lloyd | AQXP | Common Stock | D | 5,7600 | 7.812 | 45 | 7.812 | ||||
| 2015-08-14 | 2015-08-12 | 4 | Alam Kamran | AQXP | Stock Option (Right to Buy) | D | 5,76 | -20.833 | 0 | |||||
| 2015-08-14 | 2015-08-12 | 4 | Alam Kamran | AQXP | Stock Option (Right to Buy) | D | 5,76 | -8.246 | 2.170 | |||||
| 2015-08-14 | 2015-08-12 | 4 | Alam Kamran | AQXP | Common Stock | D | 18,6700 | -29.079 | -543 | 0 | ||||
| 2015-08-14 | 2015-08-12 | 4 | Alam Kamran | AQXP | Common Stock | D | 5,7600 | 20.833 | 120 | 29.079 | ||||
| 2015-08-14 | 2015-08-12 | 4 | Alam Kamran | AQXP | Common Stock | D | 5,7600 | 8.246 | 47 | 8.246 | ||||
| 2015-08-13 | 2015-08-11 | 4 | Mitchell David Chilton | AQXP | Common Stock | D | 24,3600 | 1.600 | 39 | 1.600 | ||||
| 2015-08-12 | 2015-08-10 | 4 | PFIZER INC | AQXP | Common Stock | D | 23,4112 | -58.632 | -1.373 | 975.403 | ||||
| 2015-08-12 | 2015-08-10 | 4 | PFIZER INC | AQXP | Common Stock | D | 22,5994 | -44.268 | -1.000 | 1.034.035 | ||||
| 2015-08-12 | 2015-08-10 | 4 | PFIZER INC | AQXP | Common Stock | D | 24,3129 | -31.400 | -763 | 1.078.303 | ||||
| 2015-08-12 | 2015-08-10 | 4 | PFIZER INC | AQXP | Common Stock | D | 20,3476 | -25.931 | -528 | 1.109.703 | ||||
| 2015-08-12 | 2015-08-10 | 4 | PFIZER INC | AQXP | Common Stock | D | 26,3213 | -13.109 | -345 | 1.135.634 | ||||
| 2015-08-12 | 2015-08-10 | 4 | PFIZER INC | AQXP | Common Stock | D | 25,3233 | -12.726 | -322 | 1.148.743 | ||||
| 2015-08-12 | 2015-08-10 | 4 | PFIZER INC | AQXP | Common Stock | D | 38,4947 | -11.627 | -448 | 1.161.469 | ||||
| 2015-08-12 | 2015-08-10 | 4 | PFIZER INC | AQXP | Common Stock | D | 36,3687 | -10.544 | -383 | 1.173.096 | ||||
| 2015-08-12 | 2015-08-10 | 4 | PFIZER INC | AQXP | Common Stock | D | 37,2264 | -9.901 | -369 | 1.183.640 | ||||
| 2015-08-12 | 2015-08-10 | 4 | PFIZER INC | AQXP | Common Stock | D | 39,5172 | -9.142 | -361 | 1.193.541 | ||||
| 2015-08-12 | 2015-08-10 | 4 | PFIZER INC | AQXP | Common Stock | D | 21,4506 | -8.969 | -192 | 1.202.683 | ||||
| 2015-08-12 | 2015-08-10 | 4 | PFIZER INC | AQXP | Common Stock | D | 27,3561 | -8.565 | -234 | 1.211.652 | ||||
| 2015-08-12 | 2015-08-10 | 4 | PFIZER INC | AQXP | Common Stock | D | 40,2955 | -6.073 | -245 | 1.220.217 | ||||
| 2015-08-12 | 2015-08-10 | 4 | PFIZER INC | AQXP | Common Stock | D | 35,6072 | -3.207 | -114 | 1.226.290 | ||||
| 2015-08-12 | 2015-08-10 | 4 | PFIZER INC | AQXP | Common Stock | D | 28,4670 | -2.975 | -85 | 1.229.497 | ||||
| 2015-08-12 | 2015-08-10 | 4 | PFIZER INC | AQXP | Common Stock | D | 41,2475 | -2.840 | -117 | 1.232.472 | ||||
| 2015-08-12 | 2015-08-10 | 4 | PFIZER INC | AQXP | Common Stock | D | 29,0000 | -18 | -1 | 1.235.312 | ||||
| 2015-08-12 | 2015-08-11 | 4 | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC, Inc. | AQXP | Common Stock | I | 20,7400 | -1.283.366 | -26.617 | 100.000 | ||||
| 2015-08-12 | 2015-08-10 | 4 | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC, Inc. | AQXP | Common Stock | I | 31,6600 | -231.455 | -7.328 | 1.383.366 | ||||
| 2015-08-10 | 3/A | BAKER FELIX | AQXP | Common Stock | D | 2.260 | ||||||||
| 2015-08-10 | 3/A | BAKER FELIX | AQXP | Common Stock | D | 2.260 | ||||||||
| 2015-08-10 | 3 | 667, L.P. | AQXP | Common Stock | I | 4.725.965 | ||||||||
| 2015-08-10 | 3 | 667, L.P. | AQXP | Common Stock | I | 8.075.935 | ||||||||
| 2015-08-10 | 3 | 667, L.P. | AQXP | Common Stock | I | 8.075.935 | ||||||||
| 2015-08-10 | 3 | 667, L.P. | AQXP | Common Stock | I | 4.725.965 | ||||||||
| 2015-08-10 | 3 | 667, L.P. | AQXP | Common Stock | I | 8.075.935 | ||||||||
| 2015-08-10 | 3 | 667, L.P. | AQXP | Common Stock | I | 4.725.965 | ||||||||
| 2015-08-10 | 3 | 667, L.P. | AQXP | Common Stock | I | 8.075.935 | ||||||||
| 2015-08-10 | 3 | 667, L.P. | AQXP | Common Stock | I | 4.725.965 | ||||||||
| 2015-08-10 | 3 | 667, L.P. | AQXP | Common Stock | I | 8.075.935 | ||||||||
| 2015-08-10 | 3 | 667, L.P. | AQXP | Common Stock | I | 4.725.965 | ||||||||
| 2015-08-10 | 3 | 667, L.P. | AQXP | Common Stock | I | 4.725.965 | ||||||||
| 2015-08-10 | 3 | 667, L.P. | AQXP | Common Stock | I | 8.075.935 | ||||||||
| 2015-08-10 | 3 | 667, L.P. | AQXP | Common Stock | I | 8.075.935 | ||||||||
| 2015-08-10 | 3 | 667, L.P. | AQXP | Common Stock | I | 4.725.965 | ||||||||
| 2015-03-16 | 2015-03-12 | 4 | SHREWSBURY STEPHEN B | AQXP | Stock Option (Right to Buy) | D | 12,03 | 25.000 | 25.000 | |||||
| 2015-03-16 | 2015-03-12 | 4 | Nolan Sean P. | AQXP | Stock Option (Right to Buy) | D | 12,03 | 10.000 | 10.000 | |||||
| 2015-03-16 | 2015-03-12 | 4 | Main David | AQXP | Stock Option (Right to Buy) | D | 12,03 | 65.000 | 65.000 | |||||
| 2015-03-16 | 2015-03-12 | 4 | Pelzer Robert | AQXP | Stock Option (Right to Buy) | D | 12,03 | 5.000 | 5.000 | |||||
| 2015-03-16 | 2015-03-12 | 4 | SIMPSON TODD E | AQXP | Stock Option (Right to Buy) | D | 12,03 | 5.000 | 5.000 | |||||
| 2015-03-16 | 2015-03-12 | 4 | MacKenzie Lloyd | AQXP | Stock Option (Right to Buy) | D | 12,03 | 25.000 | 25.000 | |||||
| 2015-03-16 | 2015-03-12 | 4 | LEVITT DANIEL J | AQXP | Stock Option (Right to Buy) | D | 12,03 | 5.000 | 5.000 | |||||
| 2015-03-16 | 2015-03-12 | 4 | Bridger Gary | AQXP | Stock Option (Right to Buy) | D | 12,03 | 5.000 | 5.000 | |||||
| 2015-03-16 | 2015-03-12 | 4 | Alam Kamran | AQXP | Stock Option (Right to Buy) | D | 12,03 | 25.000 | 25.000 | |||||
| 2015-02-09 | 2014-09-02 | 5 | SHREWSBURY STEPHEN B | AQXP | Common Stock | D | 8,2200 | 400 | 3 | 400 | ||||
| 2015-02-03 | 2014-03-12 | 4/A | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | AQXP | Series C Preferred Stock | I | -379.543 | 0 | ||||||
| 2015-02-03 | 2014-03-12 | 4/A | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | AQXP | Series B-2 Preferred Stock | I | -292.532 | 0 | ||||||
| 2015-02-03 | 2014-03-12 | 4/A | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | AQXP | Series B-1 Preferred Stock | I | -293.884 | 0 | ||||||
| 2015-02-03 | 2014-03-12 | 4/A | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | AQXP | Series A-2 Preferred Stock | I | -170.454 | 0 | ||||||
| 2015-02-03 | 2014-03-12 | 4/A | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | AQXP | Series A-1 Preferred Stock | I | -255.681 | 0 | ||||||
| 2015-02-03 | 2014-03-12 | 4/A | JOHNSON & JOHNSON Johnson & Johnson Development Corporation | AQXP | Common Stock | I | 11,0000 | 272.727 | 3.000 | 1.664.821 | ||||
| 2015-02-03 | 2014-03-12 | 4/A | JOHNSON & JOHNSON Johnson & Johnson Development Corporation | AQXP | Common Stock | I | 1.392.094 | 1.392.094 | ||||||
| 2015-01-13 | 2015-01-11 | 4 | Mitchell David Chilton | AQXP | Stock Option (Right to Buy) | D | 9,51 | 35.000 | 35.000 | |||||
| 2014-12-18 | 2014-12-17 | 4 | JOHNSON & JOHNSON Johnson & Johnson Development Corporation | AQXP | Common Stock | I | 7,5800 | -1.593 | -12 | 1.342.094 | ||||
| 2014-12-18 | 2014-12-16 | 4 | JOHNSON & JOHNSON Johnson & Johnson Development Corporation | AQXP | Common Stock | I | 7,6300 | -6.507 | -50 | 1.343.687 | ||||
| 2014-12-15 | 2014-12-12 | 4 | JOHNSON & JOHNSON Johnson & Johnson Development Corporation | AQXP | Common Stock | I | 7,5100 | -3.645 | -27 | 1.350.194 | ||||
| 2014-12-15 | 2014-12-11 | 4 | JOHNSON & JOHNSON Johnson & Johnson Development Corporation | AQXP | Common Stock | I | 7,5000 | -1.355 | -10 | 1.353.839 | ||||
| 2014-12-10 | 2014-12-10 | 4 | JOHNSON & JOHNSON Johnson & Johnson Development Corporation | AQXP | Common Stock | I | 7,7000 | -1.300 | -10 | 1.355.194 | ||||
| 2014-12-10 | 2014-12-09 | 4 | JOHNSON & JOHNSON Johnson & Johnson Development Corporation | AQXP | Common Stock | I | 7,7300 | -5.000 | -39 | 1.356.494 | ||||
| 2014-12-10 | 2014-12-08 | 4 | JOHNSON & JOHNSON Johnson & Johnson Development Corporation | AQXP | Common Stock | I | 7,6900 | -2.000 | -15 | 1.361.494 | ||||
| 2014-12-05 | 2014-12-05 | 4 | JOHNSON & JOHNSON Johnson & Johnson Development Corporation | AQXP | Common Stock | I | 7,7800 | -4.200 | -33 | 1.363.494 | ||||
| 2014-12-05 | 2014-12-04 | 4 | JOHNSON & JOHNSON Johnson & Johnson Development Corporation | AQXP | Common Stock | I | 7,7600 | -10.073 | -78 | 1.367.694 | ||||
| 2014-12-05 | 2014-12-03 | 4 | JOHNSON & JOHNSON Johnson & Johnson Development Corporation | AQXP | Common Stock | I | 7,7500 | -1.627 | -13 | 1.377.767 | ||||
| 2014-12-03 | 2014-12-01 | 4 | JOHNSON & JOHNSON Johnson & Johnson Development Corporation | AQXP | Common Stock | I | 7,5400 | -1.200 | -9 | 1.379.394 | ||||
| 2014-11-26 | 2014-11-26 | 4 | JOHNSON & JOHNSON Johnson & Johnson Development Corporation | AQXP | Common Stock | I | 7,6000 | -500 | -4 | 1.380.594 | ||||
| 2014-11-26 | 2014-11-25 | 4 | JOHNSON & JOHNSON Johnson & Johnson Development Corporation | AQXP | Common Stock | I | 7,8000 | -1.500 | -12 | 1.381.094 | ||||
| 2014-11-24 | 2014-11-24 | 4 | JOHNSON & JOHNSON Johnson & Johnson Development Corporation | AQXP | Common Stock | I | 8,0200 | -4.000 | -32 | 1.382.594 | ||||
| 2014-11-24 | 2014-11-21 | 4 | JOHNSON & JOHNSON Johnson & Johnson Development Corporation | AQXP | Common Stock | I | 8,2500 | -2.400 | -20 | 1.386.594 | ||||
| 2014-11-24 | 2014-11-20 | 4 | JOHNSON & JOHNSON Johnson & Johnson Development Corporation | AQXP | Common Stock | I | 8,2100 | -3.100 | -25 | 1.388.994 | ||||
| 2014-05-12 | 2014-05-08 | 4 | SHREWSBURY STEPHEN B | AQXP | Stock Option (Right to Buy) | D | 10,10 | 31.250 | 31.250 | |||||
| 2014-05-12 | 2014-05-08 | 4 | Main David | AQXP | Stock Option (Right to Buy) | D | 10,10 | 65.000 | 65.000 | |||||
| 2014-05-12 | 2014-05-08 | 4 | Alam Kamran | AQXP | Stock Option (Right to Buy) | D | 10,10 | 31.250 | 31.250 | |||||
| 2014-05-12 | 2014-05-08 | 4 | MacKenzie Lloyd | AQXP | Stock Option (Right to Buy) | D | 10,10 | 25.000 | 25.000 | |||||
| 2014-03-14 | 2014-03-12 | 4 | Main David | AQXP | Common Exchangeable Shares | D | -71.530 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Main David | AQXP | Common Exchangeable Shares | D | 11,0000 | -9.459 | -104 | 0 | ||||
| 2014-03-14 | 2014-03-12 | 4 | Main David | AQXP | Common Stock | D | 71.530 | 71.530 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Main David | AQXP | Common Special Voting Stock | D | -71.530 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Main David | AQXP | Common Special Voting Stock | D | 11,0000 | -9.459 | -104 | 71.530 | ||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Series C Preferred Stock | D | -378.786 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Series C Exchangeable Shares | D | -378.786 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Series C Preferred Stock | D | 378.786 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Series B-2 Exchangeable Shares | D | -325.035 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Series B-2 Preferred Stock | D | -325.035 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Series B-2 Preferred Stock | D | 325.035 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Series B-1 Exchangeable Shares | D | -326.538 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Series B-1 Preferred Stock | D | -326.538 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Series B-1 Preferred Stock | D | 326.538 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Series A-2 Exchangeable Shares | D | -189.393 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Series A-2 Preferred Stock | D | -189.393 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Series A-2 Preferred Stock | D | 189.393 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Series A-1 Exchangeable Shares | D | -284.090 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Series A-1 Preferred Stock | D | -284.090 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Series A-1 Preferred Stock | D | 284.090 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Common Exchangeable Shares | D | -40.147 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Common Exchangeable Shares | D | 11,0000 | 36.502 | 402 | 40.147 | ||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Common Stock | D | 1.543.989 | 1.543.989 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Series C Special Voting Stock | D | -378.786 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Series B-2 Special Voting Stock | D | -325.035 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Series B-1 Special Voting Stock | D | -326.538 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Series A-2 Special Voting Stock | D | -189.393 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Series A-1 Special Voting Stock | D | -284.090 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Common Special Voting Stock | D | -40.147 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Ventures West 8 Limited Partnership | AQXP | Common Special Voting Stock | D | 36.502 | 40.147 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Series C Preferred Stock | I | -378.786 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Series C Exchangeable Shares | I | -378.786 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Series C Preferred Stock | I | 378.786 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Series B-2 Preferred Stock | I | -325.035 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Series B-2 Exchangeable Shares | I | -325.035 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Series B-2 Preferred Stock | I | 325.035 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Series B-1 Exchangeable Shares | I | -326.538 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Series B-1 Preferred Stock | I | -326.538 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Series B-1 Preferred Stock | I | 326.538 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Series A-2 Preferred Stock | I | -189.393 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Series A-2 Exchangeable Shares | I | -189.393 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Series A-2 Preferred Stock | I | 189.393 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Series A-1 Preferred Stock | I | -284.090 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Series A-1 Exchangeable Shares | I | -284.090 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Series A-1 Preferred Stock | I | 284.090 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Common Exchangeable Shares | I | -40.147 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Common Exchangeable Shares | I | 11,0000 | 36.502 | 402 | 40.147 | ||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Common Stock | I | 1.543.989 | 1.543.989 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Series C Special Voting Stock | I | -378.786 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Series B-2 Special Voting Stock | I | -325.035 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Series B-1 Special Voting Stock | I | -326.538 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Series A-2 Special Voting Stock | I | -189.393 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Series A-1 Special Voting Stock | I | -284.090 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Common Special Voting Stock | I | -40.147 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | Bridger Gary See Note | AQXP | Common Special Voting Stock | I | 36.502 | 40.147 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | PFIZER INC | AQXP | Series C Preferred Stock | D | -301.005 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | PFIZER INC | AQXP | Series B-2 Preferred Stock | D | -327.178 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | PFIZER INC | AQXP | Series B-1 Preferred Stock | D | -334.420 | 0 | ||||||
| 2014-03-14 | 2014-03-12 | 4 | PFIZER INC | AQXP | Common Stock | D | 11,0000 | 272.727 | 3.000 | 1.235.330 | ||||
| 2014-03-14 | 2014-03-12 | 4 | PFIZER INC | AQXP | Common Stock | D | 962.603 | 962.603 | ||||||
| 2014-03-12 | 2014-03-12 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | AQXP | Series C Preferred Stock | I | -379.543 | 0 | ||||||
| 2014-03-12 | 2014-03-12 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | AQXP | Series B-2 Preferred Stock | I | -292.532 | 0 | ||||||
| 2014-03-12 | 2014-03-12 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | AQXP | Series B-1 Preferred Stock | I | -293.884 | 0 | ||||||
| 2014-03-12 | 2014-03-12 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | AQXP | Series A-2 Preferred Stock | I | -170.454 | 0 | ||||||
| 2014-03-12 | 2014-03-12 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | AQXP | Series A-1 Preferred Stock | I | -255.681 | 0 | ||||||
| 2014-03-12 | 2014-03-12 | 4 | JOHNSON & JOHNSON Johnson & Johnson Development Corporation | AQXP | Common Stock | I | 1.392.094 | 1.392.094 | ||||||
| 2014-03-10 | 2014-03-06 | 4 | SIMPSON TODD E | AQXP | Stock Option (Right to Buy) | D | 11,00 | 8.333 | 8.333 | |||||
| 2014-03-10 | 2014-03-06 | 4 | Pelzer Robert | AQXP | Stock Option (Right to Buy) | D | 11,00 | 8.333 | 14.843 | |||||
| 2014-03-10 | 2014-03-06 | 4 | LEVITT DANIEL J | AQXP | Stock Option (Right to Buy) | D | 11,00 | 8.333 | 20.051 | |||||
| 2014-03-10 | 2014-03-06 | 4 | Bridger Gary | AQXP | Stock Option (Right to Buy) | D | 11,00 | 8.333 | 8.333 | |||||
| 2014-03-06 | 3 | Jones Elaine V | AQXP | No securities are beneficially owned | D | 0 | ||||||||
| 2014-03-06 | 3 | SIMPSON TODD E | AQXP | No securities are beneficially owned | D | 0 | ||||||||
| 2014-03-06 | 3 | Main David | AQXP | Common Special Voting Stock | D | 161.978 | ||||||||
| 2014-03-06 | 3 | Main David | AQXP | Common Special Voting Stock | D | 161.978 | ||||||||
| 2014-03-06 | 3 | Ventures West 8 Limited Partnership | AQXP | Series B-1 Special Voting Stock | D | 1.834.025 | ||||||||
| 2014-03-06 | 3 | Ventures West 8 Limited Partnership | AQXP | Series B-2 Special Voting Stock | D | 1.832.522 | ||||||||
| 2014-03-06 | 3 | Ventures West 8 Limited Partnership | AQXP | Common Special Voting Stock | D | 1.511.132 | ||||||||
| 2014-03-06 | 3 | Ventures West 8 Limited Partnership | AQXP | Series A- Special Voting Stock | D | 1.791.577 | ||||||||
| 2014-03-06 | 3 | Ventures West 8 Limited Partnership | AQXP | Series A-2 Special Voting Stock | D | 1.696.880 | ||||||||
| 2014-03-06 | 3 | Ventures West 8 Limited Partnership | AQXP | Series B-1 Special Voting Stock | D | 1.834.025 | ||||||||
| 2014-03-06 | 3 | Ventures West 8 Limited Partnership | AQXP | Series B-2 Special Voting Stock | D | 1.832.522 | ||||||||
| 2014-03-06 | 3 | Ventures West 8 Limited Partnership | AQXP | Series C Special Voting Stock | D | 1.886.273 | ||||||||
| 2014-03-06 | 3 | Ventures West 8 Limited Partnership | AQXP | Series C Special Voting Stock | D | 1.886.273 | ||||||||
| 2014-03-06 | 3 | Ventures West 8 Limited Partnership | AQXP | Common Special Voting Stock | D | 1.511.132 | ||||||||
| 2014-03-06 | 3 | Ventures West 8 Limited Partnership | AQXP | Series A- Special Voting Stock | D | 1.791.577 | ||||||||
| 2014-03-06 | 3 | Ventures West 8 Limited Partnership | AQXP | Series A-2 Special Voting Stock | D | 1.696.880 | ||||||||
| 2014-03-06 | 3 | Bridger Gary See Note (9) | AQXP | Series C Special Voting Stock | I | 1.886.273 | ||||||||
| 2014-03-06 | 3 | Bridger Gary See Note (9) | AQXP | Series A-1 Special Voting Stock | I | 1.791.577 | ||||||||
| 2014-03-06 | 3 | Bridger Gary See Note (9) | AQXP | Series A-2 Special Voting Stock | I | 1.696.880 | ||||||||
| 2014-03-06 | 3 | Bridger Gary See Note (9) | AQXP | Common Special Voting Stock | I | 1.511.132 | ||||||||
| 2014-03-06 | 3 | Bridger Gary See Note (9) | AQXP | Series B-1 Special Voting Stock | I | 1.834.025 | ||||||||
| 2014-03-06 | 3 | Bridger Gary See Note (9) | AQXP | Series B-2 Special Voting Stock | I | 1.832.522 | ||||||||
| 2014-03-06 | 3 | Bridger Gary See Note (9) | AQXP | Series C Special Voting Stock | I | 1.886.273 | ||||||||
| 2014-03-06 | 3 | Bridger Gary See Note (9) | AQXP | Series A-1 Special Voting Stock | I | 1.791.577 | ||||||||
| 2014-03-06 | 3 | Bridger Gary See Note (9) | AQXP | Series A-2 Special Voting Stock | I | 1.696.880 | ||||||||
| 2014-03-06 | 3 | Bridger Gary See Note (9) | AQXP | Series B-1 Special Voting Stock | I | 1.834.025 | ||||||||
| 2014-03-06 | 3 | Bridger Gary See Note (9) | AQXP | Series B-2 Special Voting Stock | I | 1.832.522 | ||||||||
| 2014-03-06 | 3 | Bridger Gary See Note (9) | AQXP | Common Special Voting Stock | I | 1.511.132 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
